Real-time performance breakthrough again! Intel launches the second-generation Core processors for edge AI applications

The new industry-ready platform delivers exceptional deterministic performance, with the sixth edge AI suite specifically optimized for the healthcare industry.

● The second-generation Intel® Core™ processor (with full-performance cores) is an industry-ready platform designed for mission-critical edge applications.

● The Healthcare and Life Sciences Edge AI Suite provides validated reference workflows for AI-driven monitoring solutions.

At Embedded World 2026, Intel announced the second-generation Intel® Core™ processor (with full-performance cores), an industry-ready platform designed for mission-critical edge applications. Additionally, Intel unveiled the latest edge AI suite for healthcare and life sciences, offering validated reference workflows and benchmarking tools for AI-driven monitoring solutions.

"

Intel continues to lead the development of edge computing, which is also one of the company’s fastest-growing divisions. With the release of the second-generation Intel Core processor, the third-generation Core Ultra processor announced at CES this year, and our increasingly rich edge AI suites, we are providing customers with a comprehensive platform that combines groundbreaking performance, reliability, and integrated AI acceleration capabilities to meet the diverse needs of edge customers.

—Dan Rodriguez

Vice President of Intel Corporation

General Manager of the Edge Computing Division

"

Supporting Industry-Specific Real-Time Challenges

The second-generation Intel® Core™ processor was designed with the current industry operational challenges in mind: industry scenarios require handling multiple critical workloads simultaneously, from security-sensitive control systems to real-time data processing, all while ensuring precise timing and deterministic performance.

Traditional processors often force manufacturers to choose between computing power and real-time reliability, leading to complex multi-processor architectures that increase costs and system complexity. Compared to similar solutions, the second-generation Intel® Core™ processor offers superior performance in addressing these challenges.

Edge AI Suite Accelerates Healthcare AI Innovation

Intel previewed its AI suite for healthcare and life sciences, focusing on AI-driven monitoring functions. Today, monitoring is shifting from standalone devices to intelligent interconnected ecosystems. This transformation urgently requires AI-driven solutions to detect issues earlier and ensure reliable operation in real-world scenarios.

The latest edge AI suite demonstrates locally running, concurrent, multimodal workloads on Intel processors, including AI-based ECG arrhythmia detection, remote photoplethysmography, and anonymized 3D visual tracking, enabling OEMs, ODMs, and ISVs to evaluate platform performance through representative real-world scenarios rather than synthetic benchmarks.

With the recent launch of the third-generation Intel® Core™ Ultra processor, the second-generation Intel® Core™ processor (with full-performance cores), and the latest Healthcare and Life Sciences Edge AI Suite, Intel has built a comprehensive edge product portfolio to meet customer needs—from deterministic real-time control to advanced AI acceleration—accelerating innovation in manufacturing, healthcare, and emerging edge applications.

Availability

Edge systems powered by the third-generation Intel® Core™ Ultra processor and the second-generation Intel® Core™ processor (with full-performance cores) are now available.

Previews of the Healthcare and Life Sciences Edge AI Suite are accessible via GitHub, with general availability expected in Q2 2026.

Intel, the Intel logo, and other Intel marks are trademarks of Intel Corporation or its subsidiaries. Other names and brands mentioned are the property of their respective owners.